Evans R A, Flynn J, Dunstan C R, George C R
Prog Biochem Pharmacol. 1980;17:236-41.
Bone biopsies from 37 haemodialysis patients were embedded in a methyl methacrylate:hydroxyethylmethacrylate mixture and consecutive sections taken for: (1) acid phosphatase activity (osteoclasts), (2) pyronin stain for RNA (osteoblasts), and (3) fluorescence for tetracycline. Images of the three sections were traced using a camera lucida and the tracing quantitated with a digitiser. Osteomalacia (OM) was diagnosed by increased osteoid with decreased tetracycline and hyperparathyroidism (HPT) by an increased osteoclast count. OM was present in 8 patients, HPT in 11, OM + HPT in 16, and no disease in 2. Biochemistry could not predict the histology. Histologically, though HPT could be satisfactorily diagnosed, problems still remain in the definition of OM, particularly when combined with HPT.
对37名血液透析患者进行骨活检,将活检组织嵌入甲基丙烯酸甲酯:甲基丙烯酸羟乙酯混合物中,并连续切片用于:(1)酸性磷酸酶活性检测(破骨细胞),(2)RNA的派洛宁染色(成骨细胞),以及(3)四环素荧光检测。使用明箱相机对这三个切片的图像进行描绘,并通过数字化仪对描绘结果进行定量分析。骨软化症(OM)通过类骨质增加且四环素减少来诊断,甲状旁腺功能亢进症(HPT)通过破骨细胞计数增加来诊断。8名患者存在骨软化症,11名患者存在甲状旁腺功能亢进症,16名患者同时存在骨软化症和甲状旁腺功能亢进症,2名患者无疾病。生化指标无法预测组织学结果。在组织学上,虽然甲状旁腺功能亢进症能够得到满意的诊断,但在骨软化症的定义方面仍然存在问题,尤其是当与甲状旁腺功能亢进症合并存在时。